Literature DB >> 25974331

Thyroid function is associated with non-alcoholic fatty liver disease in chronic hepatitis B-infected subjects.

Wen-Jin Ding1, Man-Man Wang2, Gong-Sui Wang3, Fen Shen1, Jian-Jun Qin1, Jian-Gao Fan1.   

Abstract

BACKGROUND AND AIMS: Associations between thyroid function and non-alcoholic fatty liver disease (NAFLD) are unknown in chronic hepatitis B (CHB)-infected patients. Thus, the aim of the study was to investigate the prevalence of thyroid dysfunction and its relationship with NAFLD in CHB.
METHODS: Consecutive naive CHB infected patients that had undergone liver biopsy and serum thyroid function tests between January 2007 and December 2011 were retrospective analyzed. NAFLD was diagnosed as at least 5% biopsy-proven hepatic steatosis without significant alcohol consumption.
RESULTS: A total of 1154 non-alcoholics with CHB were included, 270 (23.39%) patients were found to have NAFLD, most of them (88.5%) with mild steatosis. The prevalence of hyperthyroidism and hypothyroidism (including subclinical and overt) was 1.56% and 1.64%, respectively, both with similar rates in patients with and without NAFLD (1.85% vs 1.47%, 1.48% vs 1.69%, respectively, both P > 0.05). The serum thyroid-stimulating hormone (TSH) level in NAFLD patients was significantly higher than that in patients without NAFLD (2.22 ± 2.13 vs 1.61 ± 1.20 mIU/L, P < 0.05). After adjustment for age and gender, the elevated TSH level was associated with increased odds of having steatosis (odds ratio1.54, 95% confidence interval 1.049-2.271) instead of viral factors and hepatic inflammation and fibrosis.
CONCLUSIONS: Thyroid dysfunction is not common in CHB-infected patients, and the prevalence of hypothyroidism in CHB individuals with or without NAFLD is similar. However, increased serum TSH concentration at the normal range is a significant predictor of hepatic steatosis in patients with CHB.
© 2015 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd.

Entities:  

Keywords:  hepatic steatosis; hepatitis B virus; thyroid function

Mesh:

Substances:

Year:  2015        PMID: 25974331     DOI: 10.1111/jgh.12998

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  9 in total

1.  Thyroid Dysfunction and Nonalcoholic Fatty Liver Disease: We Need New Larger and Well-Designed Longitudinal Studies.

Authors:  Alessandro Mantovani; Giorgio Grani
Journal:  Dig Dis Sci       Date:  2018-04-19       Impact factor: 3.199

2.  Nonalcoholic Fatty Liver Disease Is Not Associated with Thyroid Hormone Levels and Hypothyroidism: A Systematic Review and Meta-Analysis.

Authors:  Veeravich Jaruvongvanich; Anawin Sanguankeo; Sikarin Upala
Journal:  Eur Thyroid J       Date:  2017-01-21

3.  Relationship Between Thyroid Hormone and Liver Steatosis Analysis Parameter in Obese Participants: A Case-Control Study.

Authors:  Shuqin Chen; Yong Jin; Miao Xu; Pingping Zhang; Ye Zhou; Xingjun Qian; Qifa Song; Shizhong Bu; Jing Sun; Li Li
Journal:  Diabetes Metab Syndr Obes       Date:  2022-03-22       Impact factor: 3.168

4.  Relationship between Hypothyroidism and Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.

Authors:  Weiwei He; Xiaofei An; Ling Li; Xiaoqing Shao; Qian Li; Qiuming Yao; Jin-An Zhang
Journal:  Front Endocrinol (Lausanne)       Date:  2017-11-29       Impact factor: 5.555

5.  Benefits of Levothyroxine Replacement Therapy on Nonalcoholic Fatty Liver Disease in Subclinical Hypothyroidism Patients.

Authors:  Lu Liu; Yong Yu; Meng Zhao; Dongmei Zheng; Xu Zhang; Qingbo Guan; Chao Xu; Ling Gao; Jiajun Zhao; Haiqing Zhang
Journal:  Int J Endocrinol       Date:  2017-04-04       Impact factor: 3.257

Review 6.  Hypothyroidism-Induced Nonalcoholic Fatty Liver Disease (HIN): Mechanisms and Emerging Therapeutic Options.

Authors:  Daniela Maria Tanase; Evelina Maria Gosav; Ecaterina Neculae; Claudia Florida Costea; Manuela Ciocoiu; Loredana Liliana Hurjui; Claudia Cristina Tarniceriu; Mariana Floria
Journal:  Int J Mol Sci       Date:  2020-08-18       Impact factor: 5.923

7.  The relationship between non-alcoholic fatty liver disease and hypothyroidism: A systematic review and meta-analysis.

Authors:  Xiaoxu Zeng; Bin Li; Yang Zou
Journal:  Medicine (Baltimore)       Date:  2021-04-30       Impact factor: 1.817

8.  Predictors of inflammatory activity in treatment-naive hepatitis B e-antigen-negative patients with chronic hepatitis B infection.

Authors:  Jianhua Hu; Yong Wang; Gongying Jiang; Jie Zheng; Tuxiang Chen; Zhiping Chen; Meifang Yang; Xuan Zhang; Hong Zhao; Lanjuan Li
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

Review 9.  Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and opinion.

Authors:  Yi-Wen Shi; Rui-Xu Yang; Jian-Gao Fan
Journal:  World J Gastroenterol       Date:  2021-07-14       Impact factor: 5.742

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.